Filing Analysis

Regulation FD Disclosure Filed May 07, 2026
LOW

Codexis, Inc. announced its financial results for the first quarter ended March 31, 2026. The disclosure was made through a press release furnished as an exhibit to the Form 8-K.

Key Facts

  • The filing was made on May 7, 2026, to report results for the quarter ended March 31, 2026.
  • The report was filed under Item 2.02 (Results of Operations and Financial Condition).
  • The financial information was furnished as Exhibit 99.1 and is not deemed 'filed' for purposes of Section 18 of the Exchange Act.
  • The report was signed by Georgia Erbez, Chief Financial Officer and Chief Business Officer.
Officer Departure Filed Apr 14, 2026
LOW

Dennis Wolf resigned from the Board of Directors and its committees on April 8, 2026, without disagreement. Following the resignation, the Board performed a technical rebalancing of its classes, involving the resignation and immediate re-election of Dr. Esther Martinborough to a different class.

Key Facts

  • Dennis Wolf resigned from the Board, Audit Committee, and Compensation Committee effective April 8, 2026.
  • The resignation was not the result of any disagreement with the Company on operations, policies, or practices.
  • On April 10, 2026, Dr. Esther Martinborough resigned as a Class II director and was immediately re-elected as a Class III director.
  • The Class Rebalance was conducted to achieve an equal distribution of three directors per class across the three Board classes.
  • Dr. Martinborough retains her roles on the Compensation, Strategy, and Science & Technology Committees.
Regulation FD Disclosure Filed Mar 11, 2026
LOW

Codexis, Inc. announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025.

Key Facts

  • The report was filed on March 11, 2026.
  • Financial results cover the period ended December 31, 2025.
  • The announcement was made via a press release furnished as Exhibit 99.1.
  • The filing was signed by Georgia Erbez, Chief Financial Officer and Chief Business Officer.
Disclaimer: This analysis is generated by AI and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always review the original SEC filings and consult a financial advisor before making investment decisions.

Get real-time alerts for CDXS

Subscribers receive AI-powered analysis within minutes of new SEC filings — not days later.

Start 14-Day Free Trial